Relationship between the level of dietary vitamin E and the immune response of broiler chickens.
The relationship between the dietary level of vitamin E (VE) and the immune response of broilers was studied in three experiments. Immunity was assessed as antibody production to infectious bronchitis virus (IBV), SRBC, and Brucella abortus (BA) antigens, mitogenic response to phytohemagglutinin A (PHA) and concanavalin A (Con A), cutaneous basophil hypersensitivity (CBH) to PHA, and lipopolysaccharide induction of acute-phase proteins (APP) and heterophilia. A range of VE (0, 10, 17.5, 25, 37.5, 50, 100, and 200 IU/kg) levels were supplemented to a basal diet (corn-soy) containing 10.2 IU of VE/kg. We found a dose-dependent increase in antibody production in response to attenuated IBV between 0 and 25 IU/kg of supplemented VE and no further increase at higher levels. Antibody levels to SRBC were higher in birds supplemented with 50 IU of VE/kg compared to those supplemented with 0 or 200 IU/kg of VE. Antibody production in response to BA antigens was not influenced by VE. Mitogenic responses were suppressed by supplemented VE in Experiment 1 for PHA (25 IU/kg diet) and Con A (25 and 50 IU/kg diets). CBH and APP levels were not affected by VE. Heterophilia was lowest at 50 IU/kg 6 h after lipopolysaccharide injection (Experiment 1). Our study showed that moderate (25 to 50 IU/kg) levels of VE supplementation were most immunomodulatory and that high levels were less effective.
Leshchinsky
T V
TV
Department of Animal Science, University of California, Davis 95616, USA.
Klasing
K C
KC
D000209:Acute-Phase Proteins / Q000096:biosynthesis; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000917:Antibody Formation; D001491:Basophils / Q000276:immunology; D002003:Brucella abortus / Q000276:immunology; D002645:Chickens / Q000276:immunology*; D003208:Concanavalin A / Q000494:pharmacology; D004032:Diet; D004912:Erythrocytes / Q000276:immunology; D001351:Infectious bronchitis virus / Q000276:immunology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D010835:Phytohemagglutinins / Q000494:pharmacology; D012756:Sheep / Q000097:blood; D012882:Skin Tests; D014612:Vaccines / Q000276:immunology; D014810:Vitamin E / Q000008:administration & dosage*
D000209:Acute-Phase Proteins; D000914:Antibodies, Viral; D008070:Lipopolysaccharides; D010835:Phytohemagglutinins; D014612:Vaccines; D003208:Concanavalin A; D014810:Vitamin E